The Lyceum: AI Daily — Apr 19, 2026

Three currents converged this weekend: OpenAI locked a biology model behind a velvet rope, Anthropic admitted it's holding something more dangerous than what it just shipped, and DeepSeek — the lab that famously didn't need your money — is raising it. Meanwhile, 112 humanoid teams ran a half-marathon in Beijing this morning, which tells you as much about where AI is headed as any benchmark chart. The stack is getting physical, specialized, and gated — all at the same time.

• Claude Opus 4.7 (Anthropic): New flagship scoring 64.3% on SWE-bench Pro in Anthropic's reported benchmark runs (up from 53.4% in prior runs) with a new "xhigh" reasoning tier and 3x higher image resolution — same price as Opus 4.6.
• GPT-Rosalind (OpenAI): Life-sciences model with a Codex plugin connecting to 50+ scientific tools, released under trusted-access only.
• NVIDIA Nemotron 3 Super (NVIDIA): 120B-parameter open hybrid MoE with a 1M-token context window, built for long-horizon agent tasks.
• Grok 4.3 Beta + Grok Computer (xAI): Reasoning model plus a desktop agent that operates applications, exclusive to SuperGrok Heavy at $300/month.
• Kimi K2.6 Code Preview (Moonshot AI): Quietly rolled out April 13 to all subscribers with no launch event — improved agent planning and multi-step tool calls.
• Claude Design (Anthropic): Research-preview tool for generating prototypes, slides, and one-pagers from plain-language prompts — Figma shares fell intraday on the news.

Drug discovery is a 10-to-15-year marathon, and most of the wasted time lives in the early stages — figuring out what's even worth testing. OpenAI's pitch with GPT-Rosalind, named for Rosalind Franklin, is that an AI that can read the literature, query databases, design experiments, and propose sequences could compress that front end meaningfully. A companion Codex plugin wires the model into more than 50 scientific tools and data sources, per OpenAI's announcement.

The numbers are OpenAI's own, so treat them as signals: a 0.751 pass rate on BixBench, beating GPT-5.4 on six of eleven LAB-Bench 2 tasks, and — most striking — best submissions above the 95th percentile of human experts in an RNA prediction task run with Dyno Therapeutics using unpublished data, according to Axios. Amgen, Moderna, the Allen Institute, and Thermo Fisher Scientific have initial access. Novo Nordisk is in on the drug-candidate work.

What changes if it works: the timeline from target to trial compresses, and every pharma without an AI partner is suddenly behind. What failure looks like: benchmark wins that don't translate to an actual clinical candidate — the $17 billion already poured into AI-driven drug discovery since 2019 has yet to produce a large-scale trial drug. Watch for the first Rosalind-assisted molecule to enter Phase II in the next 12–18 months. The dual-use concern (AI that can design sequences can design unwelcome ones) is precisely why OpenAI kept the gate narrow.

For two years, DeepSeek was the lab that said no to China's biggest venture firms. That posture just ended. The Information, cited by Investing.com and Tech Startups, reports DeepSeek is raising at least $300 million at a valuation of at least $10 billion — its first external round. Founder Liang Wenfeng had long worried outside capital would dilute the research culture; rising infrastructure costs and more frequent outages appear to have won the argument.

The timing is loaded. DeepSeek V4 — originally slated for February, delayed multiple times — is now expected within the next few weeks, per a Reuters-sourced timeline cited by Futu. Coverage at Gizchina describes V4 as roughly a 1-trillion-parameter Mixture-of-Experts model, and reporting indicates it will run on Huawei Ascend chips — the first frontier-class model built around Chinese domestic silicon.

What changes if V4 ships as described: the assumption that US chip export controls are containing Chinese AI progress takes a direct hit, and if DeepSeek prices inference as aggressively as it has before, it forces a global price war on API economics. What failure looks like: another delay, or V4 shipping with Huawei but underperforming Western models — which would quietly vindicate the export-control thesis. DeepSeek has not publicly confirmed the fundraise, per Blockonomi, so treat the specifics as reported rather than official.

Claude Opus 4.7 landed across Claude products and major clouds at the same $5/$25 per million tokens as 4.6. The benchmark gains are real in Anthropic's reported runs: SWE-bench Pro rose from 53.4% to 64.3%; SWE-bench Verified from 80.8% to 87.6%; Cursor's internal benchmark from 58% to 70%; and Anthropic reports three times more resolved production tasks on Ractangle's SW-Ebench. Vision jumps to 2,576px on the long edge — roughly 3.75 megapixels, three times prior Claude models — which matters for any computer-use agent reading dense screenshots.

The subtext is the story. Anthropic is openly saying Opus 4.7 is not its most capable model — that's Claude Mythos, which the company is withholding because of cyber-security risk. Opus 4.7 ships with new cyber safeguards, and Anthropic says it deliberately reduced some cyber capabilities during training. This is the first model to carry the guardrails Anthropic thinks it needs before releasing a Mythos-class system more broadly.

What changes if this works: the industry accepts a new pattern where frontier labs publicly admit their strongest model is in reserve. What failure looks like: the safeguards leak, a regulator forces disclosure, or Mythos gets quietly sold to a government — which, per reporting tracked here earlier this week, is already a conversation. Watch the Cyber verification program for who gets in.

Peter Steinberger gave two talks about OpenClaw this week — a feel-good TED version and a much grimmer engineering version at the AI Engineer conference. In the engineering talk, per Latent Space's AINews coverage, Steinberger said OpenClaw is receiving roughly 60 times more security incident reports than curl, and that at least 20% of skill contributions to the project are malicious.

OpenClaw is infrastructure — developers pull it in as a dependency for agents that browse the web, run code, and touch files. A poisoned skill doesn't just break a demo; it hands an attacker a foothold inside a system with permissions a JavaScript library never had.

What changes if this escalates: enterprise security teams start freezing updates and banning unvetted agent components, which slows every team building on open-source agent stacks. What the observable signal looks like: an enterprise publicly confirming a supply-chain compromise traced to a malicious skill. If that happens in the next two weeks, it becomes the biggest agentic security story of the year. The npm supply-chain pattern is arriving in the agent layer, faster and with more blast radius.

The 2026 E-Town humanoid half-marathon kicked off this morning — 112 teams, five international, running the same 21km course as 12,000 human runners, separated by barriers. Per Global Times, this year's headline shift is the move from "human-led mode" to full autonomy, with large-scale deployment of autonomous navigation. CGTN's test-run coverage notes the environmental perception demands are what's actually hard.

The teams count grew nearly fivefold from last year's edition, per Manila Times. Sustaining dynamic balance, thermal management, and power budgets over 20 kilometers in uncontrolled conditions is a genuine engineering milestone — it's the difference between a demo-floor humanoid and one that could plausibly work a warehouse shift. AP separately reported a humanoid won the event.

What changes if this scales: physical AI moves from national-prestige project to actual factory and logistics procurement in China. What failure looks like: most teams fail early, footage goes viral for the wrong reasons, and the hype cycle resets. Finish times and failure modes post later today.

Grok 4.3 beta went live April 17 for SuperGrok Heavy subscribers at $300/month — more than ten times the industry-standard $20 tier. The model handles PDFs, PowerPoint, spreadsheets, and video input, per BuildFastWithAI's review. The more interesting piece is Grok Computer, xAI's autonomous desktop agent, entering wider beta in parallel: 4.3 is the reasoning engine, Computer is the action layer.

Treat the timeline xAI posts as aspirational. The product has real gaps (one reviewer noted Grok still has no persistent memory — you're paying $300/month for a model that forgets you between sessions).

What changes if $300 finds buyers: the subscription ceiling fractures, and every lab starts experimenting with premium tiers for unthrottled agent usage. What failure looks like: churn within 60 days and a quiet price cut. The brain-plus-hands architecture is live now, which is more than OpenAI or Anthropic can say about their equivalents.

Kimi K2.6 Code Preview rolled out April 13 to all Moonshot subscribers with no launch event — just an email. Beta testers spent a week noticing the console still said K2.5 but the model was clearly sharper, with cleaner agent planning and faster multi-step tool calls, per BuildFastWithAI. The r/LocalLLaMA thread trending today is Western developers catching up to something that already happened.

A Medium writeup claims K2.6 beats Claude Opus 4.5 at 76% lower cost — that measurement is not a published benchmark, so weight it accordingly. What's harder to dismiss is the cadence: Moonshot is shipping meaningful capability upgrades on weekly rhythms while Western coverage stays fixated on the US labs.

What changes if K3 (rumored to target 3–4 trillion parameters) lands as leaked: the "China is behind" narrative needs an asterisk. What failure looks like: the quiet releases stay quiet, and Moonshot never converts developer enthusiasm into enterprise revenue.

A robot crossed a Beijing finish line this morning, a biology model got handed the keys to unpublished RNA data, and somewhere a developer is discovering his Anthropic bill spiked because a free open-source tool was quietly borrowing his tokens. Anthropic shipped its second-best model and told us about it; OpenAI shipped a near-PhD and locked it in a vault; DeepSeek, after two years of refusing money, is raising funds amid rising infrastructure and electricity costs. The future, it turns out, still needs a power cord.

Until tomorrow.

If you know someone still mapping AI by chatbot demos, send this their way — the field left that conversation behind a while ago.